ScholarIQanswers from OpenAlex
Novo Nordisk (Finland)
InstitutionResearch output, impact & collaborations
Novo Nordisk (Finland) is a institution indexed in ScholarIQ from OpenAlex.
What is known about Novo Nordisk (Finland)?
ScholarIQrecord summary
Novo Nordisk (Finland) is a research organisation in Espoo, FI. OpenAlex records 312 works and 31,061 citations for it. 110 researchers list it as their most recent affiliation.
How many works does Novo Nordisk (Finland) have?
ScholarIQindexed works
Novo Nordisk (Finland) has 312 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.
How many citations does Novo Nordisk (Finland) have?
ScholarIQcitation count
Novo Nordisk (Finland) has 31,061 citations in the OpenAlex counts ScholarIQ stores.
How many researchers are at Novo Nordisk (Finland)?
ScholarIQresearcher count
Novo Nordisk (Finland) has 110 researchers in the ScholarIQ index.
What is the average h-index at Novo Nordisk (Finland)?
ScholarIQavg h-index
Novo Nordisk (Finland) has an average h-index of 70.5 in OpenAlex.
What is the ROR of Novo Nordisk (Finland)?
ScholarIQror
The ROR for Novo Nordisk (Finland) is on the source record.
What is the OpenAlex record for Novo Nordisk (Finland)?
ScholarIQopenalex
The OpenAlex for Novo Nordisk (Finland) is on the source record.
Who are the most-cited researchers behind Novo Nordisk (Finland)?
ScholarIQtop researchers by citations
What are the most-cited papers on Novo Nordisk (Finland)?
ScholarIQmost cited works
Association of the T-cell regulatory gene CTLA4 with susceptibility to autoimmune disease
Hironori Ueda, Joanna M. M. Howson, Laura Esposito, J. M. Heward, Snook, Giselle Chamberlain, Daniel B. Rainbow, Kara Hunter, Annabel N. Smith, Gianfranco Di Genova, Mathias Herr, Ingrid Dahlman, Felicity Payne, Deborah J. Smyth, Christopher Lowe, Rebecca C.J. Twells, Sarah Howlett, Barry Healy, Sarah Nutland, Helen Rance, Vin Everett, Luc J Smink, Alexander Lam, Heather J. Cordell, Neil Walker, Cristina Bordin, John S. Hulme, Costantino Motzo, Francesco Cucca, J. Fred Hess, Michael L. Metzker, Jane Rogers, Simon G. Gregory, Amit Allahabadia, Ratnasingam Nithiyananthan, Eva Tuomilehto‐Wolf, Jaakko Tuomilehto, Polly J. Bingley, Kathleen M. Gillespie, Dag E. Undlien, Kjersti S. Rønningen, Cristian Guja, C Ionescu-Tîrgovişte, David A. Savage, Alexander P. Maxwell, D. J. Carson, C. C. Patterson, Jayne A. Franklyn, David Clayton, Laurence B. Peterson, Linda S. Wicker, John A. Todd, Stephen Gough
Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes
Genetics of Type 1 Diabetes in Finland, John A. Todd, Neil Walker, Jason D. Cooper, Deborah J. Smyth, Kate Downes, Vincent Plagnol, Rebecca Bailey, Sergey Nejentsev, Sarah F. Field, Felicity Payne, Christopher E. Lowe, Jeffrey S. Szeszko, Jason P. Hafler, Lauren R Zeitels, Jennie H. M. Yang, Adrian Vella, Sarah Nutland, Helen E. Stevens, Helen Schuilenburg, Gillian Coleman, M Maisuria, William Meadows, Luc J Smink, Barry Healy, Oliver S. Burren, Alex A C Lam, Nigel Ovington, James E. Allen, Ellen Adlem, Hin-Tak Leung, Chris Wallace, Joanna M. M. Howson, Cristian Guja, C Ionescu-Tîrgovişte, Matthew J. Simmonds, J. M. Heward, Stephen Gough, David B. Dunger, Linda S. Wicker, David Clayton
Replication of an Association Between the Lymphoid Tyrosine Phosphatase Locus (<i>LYP/PTPN22</i>) With Type 1 Diabetes, and Evidence for Its Role as a General Autoimmunity Locus
Deborah J. Smyth, Jason D. Cooper, J Collins, J. M. Heward, Jayne A. Franklyn, Joanna M. M. Howson, Adrian Vella, Sarah Nutland, Helen Rance, Lisa M. Maier, Bryan J. Barratt, Cristian Guja, C Ionescu-Tîrgovişte, David A. Savage, David B. Dunger, Barry Widmer, David P. Strachan, Susan M. Ring, Neil Walker, David Clayton, Rebecca C.J. Twells, Stephen Gough, John A. Todd
Systemic Endothelin Receptor Blockade Decreases Peripheral Vascular Resistance and Blood Pressure in Humans
William G. Haynes, Charles J. Ferro, Kevin P.J. O’Kane, David Somerville, Charmaine C. Lomax, David J. Webb
Mendelian randomization for studying the effects of perturbing drug targets
Dipender Gill, Marios K. Georgakis, Venexia Walker, Amand F. Schmidt, Apostolos Gkatzionis, Daniel F. Freitag, Chris Finan, Aroon D. Hingorani, Joanna M. M. Howson, Stephen Burgess, Daniel I. Swerdlow, George Davey Smith, Michael V. Holmes, Martin Dichgans, Jie Zheng, Bruce M. Psaty, Neil M Davies
How much of the research on Novo Nordisk (Finland) is open access?
ScholarIQopen access share
71%OPEN ACCESS